Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial

Chinadrugtrials.org CTR20160526 (September 12, 2016), ClinicalTrials.gov NCT03084237 (March 20, 2017), EudraCT 2016-000206-10 (April 27, 2017).

Authors

Institutions

Publication Details

Journal
The Breast
Published
2025-02-04
DOI
https://doi.org/10.1016/j.breast.2025.104413
Citations
1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial

Zhongsheng Tong, Igor Bondarenko, Liangming Zhang, Futang Yang et al.
1 citations
The Breast
HER2/EGFR in Cancer Research
1.05
article

Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial

Zhongsheng Tong, Igor Bondarenko, Liangming Zhang, Futang Yang, Hryhoriy Adamchuk, Yaroslav Shparyk, Dmytro Trukhin, Tao Sun, Yuee Teng, Jinfang Zhu, Jing Li, Wei Li, Shusen Wang, Hong Zheng, Qingyuan Zhang, Haoyu Yu, Xichun Hu, Binghe Xu, Qingyu Wang
article en
1 citations

Abstract

Chinadrugtrials.org CTR20160526 (September 12, 2016), ClinicalTrials.gov NCT03084237 (March 20, 2017), EudraCT 2016-000206-10 (April 27, 2017).

The BreastVol. 80
Harbin Medical University (CN), Sun Yat-sen University (CN), Jilin University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Yuhuangding Hospital (CN), Lviv National Musical Academy named after Mykola Lysenko (UA), West China Hospital of Sichuan University (CN), Fudan University Shanghai Cancer Center (CN), Third Affiliated Hospital of Harbin Medical University (CN), First Hospital of Jilin University (CN), First Hospital of China Medical University (CN), Sun Yat-sen University Cancer Center (CN), Regional Clinical Hospital named after II Mechnikov (UA), Liaoning Cancer Hospital & Institute (CN), China Medical University (CN)
Good health and well-being
Openalex Percentile: Top 25%
HER2/EGFR in Cancer Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.